A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
Mayo Clinic
Mayo Clinic
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
Theravectys S.A.
M.D. Anderson Cancer Center
Inhibrx Biosciences, Inc
Hookipa Biotech GmbH
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
SCG Cell Therapy Pte. Ltd.
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
MedImmune LLC
Ohio State University Comprehensive Cancer Center
Stanford University
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
University of Jena
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)